Abstract: There are disclosed hybrid proteins comprising at least one signal sequence; at least one DNA binding domain; and at least one cell penetrating peptide (CPP) domain. In embodiments the CPP domain is a TAT domain, and the DNA binding domain is a HU domain. There is also disclosed the use of the hybrid proteins to introduce exogenous DNA into target cells, and methods for introducing exogenous DNA into target cells using the hybrid proteins.
Type:
Grant
Filed:
August 28, 2019
Date of Patent:
February 1, 2022
Assignee:
Symvivo Corporation
Inventors:
Herbert Alexander Graves, Mark Andrew Fox
Abstract: There are disclosed hybrid proteins comprising at least one signal sequence; at least one DNA binding domain; and at least one cell penetrating peptide (CPP) domain. In embodiments the CPP domain is a TAT domain, and the DNA binding domain is a HU domain. There is also disclosed the use of the hybrid proteins to introduce exogenous DNA into target cells, and methods for introducing exogenous DNA into target cells using the hybrid proteins.
Type:
Grant
Filed:
October 20, 2016
Date of Patent:
October 8, 2019
Assignee:
Symvivo Corporation
Inventors:
Herbert Alexander Graves, Mark Andrew Fox
Abstract: There are disclosed nucleic acid vectors for use in both gram positive and gram negative bacteria. In embodiments the vectors comprise a prokaryotic expression cassette and in embodiments comprise a eukaryotic expression cassette. In embodiments the vectors encode a hybrid protein comprising a DNA binding domain, a CPP domain and a signal sequence.
Type:
Grant
Filed:
February 12, 2015
Date of Patent:
September 4, 2018
Assignee:
Symvivo Corporation
Inventors:
Herbert Alexander Graves, Mark Andrew Fox, Sheetal Raithatha, Umesh Ramachandran